Annual Cash & Cash Equivalents
$10.48 M
-$24.19 M-69.78%
31 December 2023
Summary:
Dare Bioscience annual cash & cash equivalents is currently $10.48 million, with the most recent change of -$24.19 million (-69.78%) on 31 December 2023. During the last 3 years, it has risen by +$5.81 million (+124.35%). DARE annual cash & cash equivalents is now -86.20% below its all-time high of $75.91 million, reached on 31 December 2015.DARE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$11.23 M
-$5.18 M-31.57%
30 September 2024
Summary:
Dare Bioscience quarterly cash and cash equivalents is currently $11.23 million, with the most recent change of -$5.18 million (-31.57%) on 30 September 2024. Over the past year, it has dropped by -$2.66 million (-19.16%). DARE quarterly cash and cash equivalents is now -86.86% below its all-time high of $85.48 million, reached on 30 June 2015.DARE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DARE Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.8% | -19.2% |
| 3 y3 years | +124.3% | -75.3% |
| 5 y5 years | +53.9% | +361.3% |
DARE Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -79.7% | +124.3% | -78.3% | +209.4% |
| 5 y | 5 years | -79.7% | +124.3% | -78.3% | +361.3% |
| alltime | all time | -86.2% | >+9999.0% | -86.9% | >+9999.0% |
Dare Bioscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.23 M(-31.6%) |
| June 2024 | - | $16.41 M(+352.1%) |
| Mar 2024 | - | $3.63 M(-65.3%) |
| Dec 2023 | $10.48 M(-69.8%) | $10.48 M(-24.6%) |
| Sept 2023 | - | $13.89 M(+4.2%) |
| June 2023 | - | $13.33 M(-32.8%) |
| Mar 2023 | - | $19.83 M(-42.8%) |
| Dec 2022 | $34.67 M(-32.9%) | $34.67 M(-14.2%) |
| Sept 2022 | - | $40.39 M(+25.9%) |
| June 2022 | - | $32.07 M(-18.4%) |
| Mar 2022 | - | $39.32 M(-23.9%) |
| Dec 2021 | $51.67 M(+1006.6%) | $51.67 M(+13.4%) |
| Sept 2021 | - | $45.57 M(+400.1%) |
| June 2021 | - | $9.11 M(+18.9%) |
| Mar 2021 | - | $7.66 M(+64.0%) |
| Dec 2020 | $4.67 M(-2.3%) | $4.67 M(-13.4%) |
| Sept 2020 | - | $5.39 M(+0.8%) |
| June 2020 | - | $5.35 M(+5.9%) |
| Mar 2020 | - | $5.05 M(+5.6%) |
| Dec 2019 | $4.78 M | $4.78 M(+96.3%) |
| Sept 2019 | - | $2.44 M(-56.8%) |
| June 2019 | - | $5.63 M(+60.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $3.50 M(-48.5%) |
| Dec 2018 | $6.81 M(-10.0%) | $6.81 M(-28.6%) |
| Sept 2018 | - | $9.54 M(-23.4%) |
| June 2018 | - | $12.45 M(-20.3%) |
| Mar 2018 | - | $15.63 M(+106.7%) |
| Dec 2017 | $7.56 M(>+9900.0%) | $7.56 M(-11.4%) |
| Sept 2017 | - | $8.53 M(+17.7%) |
| June 2017 | - | $7.24 M(-39.8%) |
| Mar 2017 | - | $12.03 M(>+9900.0%) |
| Dec 2016 | $44.60 K(-99.9%) | $44.60 K(-99.9%) |
| Sept 2016 | - | $38.06 M(-19.4%) |
| June 2016 | - | $47.19 M(-22.0%) |
| Mar 2016 | - | $60.52 M(-20.3%) |
| Dec 2015 | $75.91 M(+48.3%) | $75.91 M(-2.2%) |
| Sept 2015 | - | $77.63 M(-9.2%) |
| June 2015 | - | $85.48 M(+51.8%) |
| Mar 2015 | - | $56.32 M(+10.0%) |
| Dec 2014 | $51.17 M(+832.5%) | $51.17 M(-11.4%) |
| Sept 2014 | - | $57.79 M(-10.1%) |
| June 2014 | - | $64.27 M(+659.0%) |
| Mar 2014 | - | $8.47 M(+54.3%) |
| Dec 2013 | $5.49 M(-67.2%) | $5.49 M |
| Dec 2012 | $16.71 M | - |
FAQ
- What is Dare Bioscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dare Bioscience?
- What is Dare Bioscience annual cash & cash equivalents year-on-year change?
- What is Dare Bioscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Dare Bioscience?
- What is Dare Bioscience quarterly cash and cash equivalents year-on-year change?
What is Dare Bioscience annual cash & cash equivalents?
The current annual cash & cash equivalents of DARE is $10.48 M
What is the all time high annual cash & cash equivalents for Dare Bioscience?
Dare Bioscience all-time high annual cash & cash equivalents is $75.91 M
What is Dare Bioscience annual cash & cash equivalents year-on-year change?
Over the past year, DARE annual cash & cash equivalents has changed by -$24.19 M (-69.78%)
What is Dare Bioscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DARE is $11.23 M
What is the all time high quarterly cash and cash equivalents for Dare Bioscience?
Dare Bioscience all-time high quarterly cash and cash equivalents is $85.48 M
What is Dare Bioscience quarterly cash and cash equivalents year-on-year change?
Over the past year, DARE quarterly cash and cash equivalents has changed by -$2.66 M (-19.16%)